首页> 外国专利> Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl-aminometyl}-kroman

Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl-aminometyl}-kroman

机译:克里斯塔林斯克hydroklorid av(R)-(-)-2- {N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl | -aminometyl} -克罗曼语

摘要

The Invention relates to the modification of the Crystalline hydrochloride of compound V (R) - (-) - 2 - {n - [4 - (1,1 dioxide - 3 - oxo 2,3 dihydro - - 2 - - benzisotiazol il) butyl] - Aminomethyl - chromane},Formula (i) which is stable at Ambient temperature.The modification is apropiadaespecialmente hydrochloride Crystalline V for the preparation of Solid Drugs, especially drugs for the treatment of neuronal Degeneration.The invencionse also refers to the process for preparing Said hydrochloride, medicines that contain, the use thereof for preparing dichosmedicamentos,A composition for the treatment and Prevention of neuronal Degeneration due to Ischemic Events and a method to try and prevent these degenerations.
机译:本发明涉及化合物V(R)-(-)-2-{n-[4-(1,1二氧化物-3-氧代2,3二氢-2-2--苯并异噻唑il)]的盐酸盐结晶的改性丁基]-氨基甲基-苯并二氢吡喃},在室温下稳定的式(i)。该修饰为制备固体药物特别是用于治疗神经元变性的药物的盐酸丙酸专用结晶V。所述盐酸盐的制备,包含该盐酸盐的药物,其用于制备二chosdicicamentos的用途,用于治疗和预防缺血性事件引起的神经元变性的组合物以及尝试和预防这些变性的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号